Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Yoshikawa

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Physical Review Letters|March 24, 2005
Superradiant light scattering from thermal atomic vaporsYutaka Yoshikawa, Yoshio Torii, Takahiro Kuga
International Journal of Molecular Sciences|December 8, 2017
Anti-Diabetic Effect of Organo-Chalcogen (Sulfur and Selenium) Zinc Complexes with Hydroxy-Pyrone Derivatives on Leptin-Deficient Type 2 Diabetes Model ob/ob MiceTakayuki Nishiguchi, Yutaka Yoshikawa, Hiroyuki Yasui
Biofactors (Oxford, England)|December 7, 2007
Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activitiesYusuke Adachi, Yutaka Yoshikawa, Hiromu Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2011
[Challenge of studies on the development of new Zn complexes to treat diabetes mellitus]Yutaka Yoshikawa, Hiromu Sakurai, Hiroyuki Yasui
Biological & Pharmaceutical Bulletin|June 13, 2012
Development of a highly sensitive methodology for quantitative determination of fexofenadine in a microdose study by multiple injection method using ultra-high performance liquid chromatography with tandem mass spectrometryYukari Tanaka, Yutaka Yoshikawa, Hiroyuki Yasui
The Journal of Pharmacy and Pharmacology|March 3, 2007
Improvement of hyperglycaemia and metabolic syndromes in type 2 diabetic KKAy mice by oral treatment with [meso-tetrakis(4-sulfonatophenyl) porphyrinato]oxovanadium(IV)(4-) complexTapan Kumar Saha, Yutaka Yoshikawa, Hiromu Sakurai
Chemmedchem|January 25, 2007
A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) miceTapan K Saha, Yutaka Yoshikawa, Hiromu Sakurai
Journal of Inorganic Biochemistry|June 1, 2005
A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modesYutaka Yoshikawa, Mayuko Kondo, Hiromu Sakurai, et al.
Chemical & Pharmaceutical Bulletin|February 11, 2003
Anti-diabetes effect of Zn(II)/carnitine complex by oral administrationYutaka Yoshikawa, Eriko Ueda, Hiromu Sakurai, et al.
Physical Review Letters|February 1, 2008
Holographic storage of multiple coherence gratings in a Bose-Einstein condensateYutaka Yoshikawa, Kazuyuki Nakayama, Yoshio Torii, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Physical Review Letters|March 24, 2005
Superradiant light scattering from thermal atomic vaporsYutaka Yoshikawa, Yoshio Torii, Takahiro Kuga
International Journal of Molecular Sciences|December 8, 2017
Anti-Diabetic Effect of Organo-Chalcogen (Sulfur and Selenium) Zinc Complexes with Hydroxy-Pyrone Derivatives on Leptin-Deficient Type 2 Diabetes Model ob/ob MiceTakayuki Nishiguchi, Yutaka Yoshikawa, Hiroyuki Yasui
Biofactors (Oxford, England)|December 7, 2007
Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activitiesYusuke Adachi, Yutaka Yoshikawa, Hiromu Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2011
[Challenge of studies on the development of new Zn complexes to treat diabetes mellitus]Yutaka Yoshikawa, Hiromu Sakurai, Hiroyuki Yasui
Biological & Pharmaceutical Bulletin|June 13, 2012
Development of a highly sensitive methodology for quantitative determination of fexofenadine in a microdose study by multiple injection method using ultra-high performance liquid chromatography with tandem mass spectrometryYukari Tanaka, Yutaka Yoshikawa, Hiroyuki Yasui
The Journal of Pharmacy and Pharmacology|March 3, 2007
Improvement of hyperglycaemia and metabolic syndromes in type 2 diabetic KKAy mice by oral treatment with [meso-tetrakis(4-sulfonatophenyl) porphyrinato]oxovanadium(IV)(4-) complexTapan Kumar Saha, Yutaka Yoshikawa, Hiromu Sakurai
Chemmedchem|January 25, 2007
A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) miceTapan K Saha, Yutaka Yoshikawa, Hiromu Sakurai
Journal of Inorganic Biochemistry|June 1, 2005
A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modesYutaka Yoshikawa, Mayuko Kondo, Hiromu Sakurai, et al.
Chemical & Pharmaceutical Bulletin|February 11, 2003
Anti-diabetes effect of Zn(II)/carnitine complex by oral administrationYutaka Yoshikawa, Eriko Ueda, Hiromu Sakurai, et al.
Physical Review Letters|February 1, 2008
Holographic storage of multiple coherence gratings in a Bose-Einstein condensateYutaka Yoshikawa, Kazuyuki Nakayama, Yoshio Torii, et al.
Pageof 10